| Medications | No. of patients, n = 193 (%) | Strengtha (mg) | Route | Directions |
| Statins |
|
|
|
|
| Atorvastatin | 170 (88.1) | 28.9 ± 24.0 | PO | QD (x167) & Q2D (x3) |
| Pravastatin | 6 (3.1) | 31.3 ± 28.9 | PO | QD |
| Simvastatin | 5 (2.6) | 26.0 ± 13.4 | PO | QD |
| Rosuvastatin | 1 (0.5) | 20 | PO | QD |
| Lovastatin | 1 (0.5) | 5 | PO | QD |
| Fluvastatin | 0 | - | - | - |
| None | 10 (5.2) | - | - | - |
| Atorvastatin-equivalentb | 183 (94.8) | 27.7 ± 23.8 | PO | QD (x180) & Q2D (x3) |
| ACE-inhibitors |
|
|
|
|
| Quinapril | 102 (52.8) | 29.5 ± 15.3 | PO | QD |
| Ramipril | 16 (8.3) | 7.1 ± 3.6 | PO | QD (x15) & BID (x1) |
| Lisinopril | 6 (3.1) | 17.5 ± 8.8 | PO | QD |
| Enalapril | 3 (1.6) | 7.5 ± 4.3 | PO | QD (x2) & BID (x1) |
| Non-dihydropyridine CCB |
|
|
|
|
| Diltiazem | 101 (52.3) | 218.3 ± 93.9 | PO | QD |